Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $12.7800 (0.87%) ($12.6000 - $12.9300) on Tue. Jun. 6, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 31 | Latest Price | $12.7800(0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1% a day on average for past five trading days. | Weekly Trend | HALO declines -4.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.415% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
1 - 5 Day Possible Target | $0.88(-93.11%) | Resistance Level | $13.11 | 5 Day Moving Average | $12.43(2.82%) | 10 Day Moving Average | $12.49(2.32%) | 20 Day Moving Average | $13.11(-2.52%) | To recent high | -12.9% | To recent low | 8.3% | Market Cap | $1.747b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |